Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 envelope glycoprotein gp41 membrane-proximal external region (MPER) is a highly conserved, tryptophan-rich segment located at the C-terminal end of the gp41 ectodomain, adjacent to the transmembrane domain (PMID: 22106361). It plays a vital role in the fusion of the viral and host cell membranes by stabilizing the pre-hairpin intermediate and facilitating the formation of the six-helix bundle (PMID: 15661915). Because of its critical function and high sequence conservation across various HIV-1 strains, the MPER is a key target for broadly neutralizing antibodies (bNAbs) such as 2F5, 4E10, and 10E8 (PMID: 23021216). These antibodies neutralize the virus by binding to the MPER during the fusion process, thereby preventing the entry of the viral genome into the host cell (PMID: 24089446). However, the MPER is relatively inaccessible to the immune system due to steric hindrance from the gp120/gp41 trimer and its proximity to the viral lipid bilayer (PMID: 21835245). Additionally, some MPER-targeting antibodies show polyreactivity with host lipids, which poses a significant challenge for vaccine design and therapeutic development due to potential safety concerns (PMID: 15845852).
Neutralization of HIV-1 by binding to the MPER of gp41, which prevents the formation of the six-helix bundle and inhibits the fusion of viral and host cell membranes (PMID: 15661915, PMID: 23021216).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 envelope glycoprotein gp41 membrane-proximal external region (MPER) (HIV-1 gp41 MPER).